Close Menu

Australian researchers led by Cathy Jensen looked into whether SNPs associated with risk of multiple sclerosis also affect the severity of the disease. To do so, they genotyped seven SNPs in more than a thousand people with MS and correlated that with clinical outcome measures such as age of onset, MS severity score, and the time interval between first demyelinating event and first relapse. The researchers found no association between those clinical outcomes and the SNPs under study.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.